Pretreatment with the protein kinase C activator phorbol 12,13- dibutyrate attenuates the ethanol-induced loss of the righting reflex in mice: Modification by diabetes

Brain Research

Volumn 764, Issue 1-2, 1997, Pages 244-248

  Ohsawa, Masahiro ^a   Kamei, Junzo ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Calphostin C; Diabetes; Ethanol; Phorbol 12,13 dibutyrate; Protein kinase C; Righting reflex

Indexed keywords

PHORBOL DIBUTYRATE; PROTEIN KINASE C;

ALCOHOL CONSUMPTION; ALCOHOL INTOXICATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RIGHTING REFLEX;

ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ETHANOL; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED ICR; MUSCULOSKELETAL EQUILIBRIUM; PHORBOL 12,13-DIBUTYRATE; PROTEIN KINASE C;

EID: 0030768295     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00601-X     Document Type: Article

References (43)

1. D.M. Ackerman, Continuous studies on the effect of experimental diabetes on drug metabolism, Fed. Proc. 35 (1976) 407.
2. D.M. Ackerman, K.C. Leibman, Effect of experimental diabetes on drug metabolism, Fed. Proc. 34 (1975) 761.
3. H.H. Allison, T.J. Cicero, Alcohol acutely depresses myoinositol 1-phosphate levels in the male rat cerebral cortex, J. Pharmacol. Exp. Ther. 231 (1980) 24-27.
4. R. Boton, D. Singer, N. Dascal, Inactivation of calcium-activated chloride conductance in Xenopus oocytes: role of calcium and protein kinase C, Pflügers Arch. 416 (1990) 1-6.
5. R. Chandrasekhar, H.M. Nuang, G.Y. Sun, Alterations in rat brain polyphosphoinositide metabolism due to acute ethanol administration, J. Pharmacol. Exp. Ther. 245 (1980) 120-123.
6. V.B.S. Chauban, H. Brockerhoff, Phenobarbital completes with diacylglycerol for protein kinase C, Life Sci. 40 (1987) 89-93.
7. I.R. Coe, L. Yao, I. Diamond, A.S. Gordon, The role of protein kinase C in cellular tolerance to ethanol, J. Biol. Chem. 271 (1996) 29468-29472.
8. P.A. Craven, F.R. De Rubertis, Protein kinase C is activated in glomeruli from streptozotocin diabetic rats, J. Clin. Invest. 83 (1989) 1667-1675.
9. R.A. Deitrich, P.A. Bludeau, R.C. Baker, Investigation of the role of protein kinase C in the acute sedative effects of ethanol, Alcoholism (NY) 13 (1989) 737-745.
10. R.A. Deitrich, T.V. Dunwiddie, R.A. Harris, Mechanism of action of ethanol: initial central nervous system actions, Pharmacol. Rev. 41 (1989) 489-537.
11. I.C.R. Fernando, G. Curzon, Effect of D-amphetamine on tryptophan and other aromatic amino acids in brain, Eur. J. Pharmacol. 49 (1974) 339-349.
12. S. Firestone, L.L. Firestone, Staurosporine, a protein kinase inhibitor, increases the intoxicating potencies of ethanol and other n-alkanols in Rana pipiens tadpoles, Alcoholism (NY) 19 (1995) 416-419.
13. S. Firestone, K. Gray, L.L. Firestone, General anesthetics and ethanol inhibit enzymatic activity of CNS-derived protein kinase C, Anesthesiology 73 (1990) A706.
14. D.M. Gilliam, A.C. Collins, Concentration-dependent effects of ethanol in long-sleep and short-sleep mice, Alcoholism (NY) 7 (1983) 337-342.
15. R.A. Gonzales, P.L. Hoffman, Receptor-gated ion channels may be selective CNS targets for ethanol, Trends Pharmacol. Sci. 12 (1991) 1-3.
16. M.J. Haley, W.G. McCormic, Pharmacological effects produced by intracerebral injections of drugs in the conscious mice, Br. J. Pharmacol. 12 (1957) 12-15.
17. G.K. Hanazono, M.G. Cote, G.L. Plaa, Potentiation of carbon tetrachloride-induced hepatotoxicity in alloxon- or streptozotocin-diabetic rats, J. Pharmacol. Exp. Ther. 192 (1975) 592-604.
18. G.K. Hanazono, H. Witschi, G.L. Plaa, Potentiation of the hepatotoxic responses to chemicals in alloxon-diabetic rats, Proc. Soc. Exp. Biol. Med. 149 (1975) 903-907.
19. R.A. Harris, S.J. McQuilkin, R. Paylor, A. Abeliovich, S. Tonegawa, J.M. Wehner, Mutant mice lacking the γ isoform of protein kinase C show decreased behavioral actions of ethanol and altered function of γ-aminobutyrate type A receptors, Proc. Natl. Acad. Sci. USA 92 (1995) 3658-3662.
20. T. Inoguchi, R. Battan, E. Handler, J.R. Sportsman, W. Health, G.L. King, Preferential elevation of protein kinase C isoform β11 and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation, Proc. Natl. Acad. Sci. USA 89 (1992) 11059-11063.
21. J. Kamei, N. Kawashima, Y. Kasuya, Role of spleen or spleen produces in the deficiency morphine-induced analgesia in diabetic mice, Brain Res. 576 (1992) 139-142.
22. K. Kato, S. Kaneko, Y. Nomura, Phorbol ester inhibition of current response and stimultaneous protein phosphorylation in Xenopus oocytes injected with brain mRNA, J. Neurochem. 50 (1988) 766-773.
23. G.L. King, S. Johnson, G. Wu, Possible growth modulators involved in the pathogenesis of diabetic proliferate retinopathy, in: B. Westermark, C. Betscholtz, T. Hökfelt (Eds.), Growth Factors in Health and Diseases, Elsevier, Amsterdam, 1990, pp. 303-317.
24. E. Kobayashi, N. Nakano, M. Morimoto, T. Tamaoki, Calphostin C (UCN-1028C), a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C, Biochem. Biophys. Res. Commun. 159 (1989) 548-553.
25. P.D. Lamson, M.E. Greig, C.J. Hobdy, Modification of barbiturate anesthesia by glucose, intermediary metabolites and certain other substances, J. Pharmacol. Exp. Ther. 103 (1951) 460-470.
26. H.M. Lee, N.J. Friedman, H.H. Loh, Effect of acute and chronic ethanol treatment on rat brain phospholipid turnover, Biochem. Pharmacol. 29 (1980) 2815-2818.
27. R.G. MacKenzie, M.E. Trulson, Reduced sensitivity to L-tryptophan and p-chloroamphetamine in streptozotocin-diabetic rats, J. Pharm. Pharmacol. 30 (1989) 131-132.
28. R.J. Marley, L.L. Miner, K.M. Wehner, A.C. Collins, Differential effects of central nervous system depressants in long-sleep and short-sleep mice, J. Pharmacol. Exp. Ther. 238 (1986) 1028-1033.
29. J.F. Marshall, Further analysis of the resistance of the diabetic rat to D-amphetamine, Pharmacol. Biochem. Behav. 8 (1978) 281-286.
30. J.F. Marshall, Resistance of alloxan-diabetic rats to the behavioral activation induced by D-amphetamine: partial restoration with high fat/protein diet, Physiol. Behav. 20 (1978) 319-322.
31. J.F. Marshall, M.I. Friedman, T.G. Haffner, Reduced anorexic and locomotor-stimulant action of D-amphetamine in alloxan-diabetic rats, Brain Res. 111 (1976) 428-432.
32. J.F. Marshall, M.I. Friedman, T.G. Haffner, Reduced anorexic and locomotor-stimulant action of amphetamine in experimental diabetes mellitus: relation to brain catecholamines, in: S. Garattiniand, R. Samanin (Eds.), Central Mechanisms of Anorectic Drugs, Raven Press, New York, 1978, pp. 111-125.
33. O. Moran, N. Dascal, Protein kinase C modulates neurotransmitter responses in Xenopus oocytes injected with brain RNA, Mol. Brain Res. 5 (1989) 193-202.
34. T. Mori, Y. Takai, Y. Minakuchi, B. Yu, Y. Nishizuka, Inhibitory action of chlorpromazine, dibucaine, and other phospholipid-interacting drugs on calcium-activated, phospholipid-dependent protein kinase, J. Biol. Chem. 255 (1980) 8378-8380.
35. Y. Nishizuka, The molecular heterogeneity of protein kinase C and its implications for cellular regulation, Science 334 (1988) 661-665.
36. T. Shiba, T. Inoguchi, R. Sportsman, W. Health, S.E. Bursell, G.L. King, Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation, Am. J. Physiol. 265 (1993) E787-E793.
37. G.S. Simon, W.L. Dewey, Narcotics and diabetes. I. The effects of streptozotocin-induced diabetes on the antinociceptive potency of morphine, J. Pharmacol. Exp. Ther. 218 (1981) 318-323.
38. S.J. Slater, K.J.A. Cox, J.V. Lombardi, C. Ho, M.B. Kelly, E. Rubin, C.D. Stubbs, Inhibition of protein kinase C by alcohols and anesthetics, Nature 364 (1993) 82-84.
39. A. Strother, Effects of glucose on enzyme activity and duration of drug action, Fed. Proc. 38 (1979) 366.
40. A. Strother, J.K. Throckmorton, C. Herzer, The influence of high sugar consumption by mice on the duration of action of barbiturates and in vitro metabolism of barbiturates, aniline and p-nitroanisole, J. Pharmacol. Exp. Ther. 179 (1971) 490-498.
41. Y.P. Tan, A. Marty, Protein kinase C-mediated desensitization of the muscarinic response in rat lacrimal gland cells, J. Physiol. 433 (1991) 357-371.
42. Y. Tanaka, A. Kashiwagi, T. Ogawa, N. Abe, T. Asahina, M. Ikebuchi, Y. Takagi, Y. Shigeta, Effect of verapamil on cardiac protein kinase C activity in diabetic rats, Eur. J. Pharmacol. 200 (1991) 353-356.
43. B.A. Wolf, J.R. Williamson, R.A. Easom, K. Chang, W.R. Sherman, J. Turk, Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels, J. Clin. Invest. 87 (1990) 31-38.